Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

39
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
39
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

4.6K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.6K
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

2.0K
Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
2.0K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

11
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
11
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

13
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
13

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The SINTER study: a recall-by-genotype design with multidimensional musculoskeletal phenotyping across internal-medicine outpatient clinics.

European journal of epidemiology·2026
Same author

Effect of an early time restricted eating Mediterranean diet compared to naltrexone/bupropion on liver fibrosis in people with cardiometabolic risk factors in a hospital outpatient clinic: study protocol for a randomised controlled trial (MEDFAST trial).

BMJ open·2026
Same author

Reduced thyroid hormone transport in a human placental model with inhibited MCT8.

European thyroid journal·2026
Same author

Evaluating the utility of ICG-based NIR imaging for small intestine neuroendocrine tumors: Challenges and the need for tumor-specific tracers.

Surgical oncology·2026
Same author

The Role of Thyroidectomy in the Management of Thyroglossal Duct Carcinoma: A Systematic Review.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

Vitamin D Supplementation to Prevent Post-Thyroidectomy Hypocalcemia.

Clinical endocrinology·2026
Same journal

Obesity-related thyroid reflections: from weight gain to weight loss.

European thyroid journal·2026
Same journal

Triiodothyroacetic acid exerts tissue-specific thyromimetic effects without tachycardia and hyperthermia in male mice.

European thyroid journal·2026
Same journal

Single-cell RNA sequencing: a powerful tool to study heterogeneity in papillary and anaplastic thyroid carcinoma.

European thyroid journal·2026
Same journal

Estimation of the delay for resumption of breastfeeding after 131-iodine therapy by milk radioactivity measurement.

European thyroid journal·2026
Same journal

Optimizing Frozen Section Sampling for Thyroid Follicular Neoplasms through Intraoperative Ultrasound Guidance.

European thyroid journal·2026
Same journal

The Effect of Iodinated Contrast Media on Thyroid (Dys)function in Children.

European thyroid journal·2026
查看所有相关文章

相关实验视频

Updated: Jul 17, 2025

Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

338

在甲状腺手术后进行管理的基于症状的算法:一个前性的多中心研究.

Caroline M J van Kinschot1,2, Ivona Lončar3, Tessa M van Ginhoven3

  • 1Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands.

European thyroid journal
|September 1, 2023
PubMed
概括
此摘要是机器生成的。

一个新的基于症状的治疗算法,用于甲状腺切除术后的低血症,安全地减少补充剂. 这种方法减少了对和阿尔法醇的需求,尽管相关问题的医院访问增加了.

关键词:
过低血症 (hypocalcemia) 的情况甲状腺过敏症 (hypoparathyroidism) 是一种严重的疾病.有症状的低血症.甲状腺切除术是指甲状腺切除术.处理算法处理算法

更多相关视频

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.7K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

561

相关实验视频

Last Updated: Jul 17, 2025

Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

338
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.7K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

561

科学领域:

  • 内分泌学 在内分泌学.
  • 手术管理的手术管理.
  • 代谢障碍 代谢障碍 代谢障碍

背景情况:

  • 缺乏基于证据的指导方针来管理甲状腺切除术后的低血症.
  • 目前的治疗通常依赖于生化监测,不太重视基于症状的方法.
  • 需要标准化,有效的协议来管理甲状腺手术后的水平.

研究的目的:

  • 评估一种新的基于症状的治疗算法,用于甲状腺切除术后的低血症.
  • 评估一项协议化方法的有效性,以逐步淘汰和阿尔法醇补充剂.
  • 为了将新算法与基于生物化学的历史治疗策略进行比较.

主要方法:

  • 未来的多中心研究比较一个新的基于症状的算法与历史的队列.
  • 根据新的算法管理患者,重点关注症状表现和结构化的断奶协议.
  • 主要结局:需要补充和/或阿尔法醇的患者比例;次要结局:补充的并发症和预测因素.

主要成果:

  • 新的算法显著降低了在术后第一年 (OR:0.36) 和12个月 (OR:0.51) 中接受补充剂的患者比例.
  • 没有观察到与有关的严重并发症,但急诊室的访问和因低血症的再入院增加了 (OR分别为11.5和3.46).
  • 副甲状腺激素 (PTH) 从手术前到手术后的比例变化是补充剂的独立预测因素 (OR: 1.04).

结论:

  • 基于症状的治疗有效地减少了甲状腺切除术后的补充剂.
  • 虽然算法是安全的,但它导致了与相关的医院访问的增加.
  • 未来的个性化治疗应考虑预测因素,如对于患有延迟症状低血症风险的患者的PTH变化.